blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2523730

EP2523730 - METHODS OF TREATING GLUCOSE METABOLISM DISORDERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.11.2014
Database last updated on 05.07.2024
Most recent event   Tooltip21.11.2014Application deemed to be withdrawnpublished on 24.12.2014  [2014/52]
Applicant(s)For all designated states
NGM Biopharmaceuticals, Inc.
630 Gateway Boulevard
South San Francisco, California 94080 / US
[2012/47]
Inventor(s)01 / CAO, Zhaodan
630 Gateway Boulevard
South San Francisco California 94080 / US
02 / LU, Yarong
630 Gateway Boulevard
South San Francisco California 94080 / US
03 / ZHANG, Peng
630 Gateway Boulevard
South San Francisco California 94080 / US
04 / KAPLAN, Daniel David
630 Gateway Boulevard
South San Francisco California 94080 / US
 [2012/47]
Representative(s)Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2012/47]Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date11733220.507.01.2011
WO2011US20547
Priority number, dateUS20100407394P27.10.2010         Original published format: US 407394 P
US20100295109P14.01.2010         Original published format: US 295109 P
[2012/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011087964
Date:21.07.2011
Language:EN
[2011/29]
Type: A1 Application with search report 
No.:EP2523730
Date:21.11.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 21.07.2011 takes the place of the publication of the European patent application.
[2012/47]
Search report(s)International search report - published on:US21.07.2011
(Supplementary) European search report - dispatched on:EP20.09.2013
ClassificationIPC:A61P3/08, A61K38/17
[2013/43]
CPC:
A61K38/1709 (EP,US); A61P3/00 (EP); A61P3/08 (EP);
A61P3/10 (EP)
Former IPC [2012/47]A61P3/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/47]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON GLUKOSESTOFFWECHSELERKRANKUNGEN[2012/47]
English:METHODS OF TREATING GLUCOSE METABOLISM DISORDERS[2012/47]
French:MÉTHODES DE TRAITEMENT DES TROUBLES DU MÉTABOLISME DU GLUCOSE[2012/47]
Entry into regional phase06.08.2012National basic fee paid 
06.08.2012Search fee paid 
06.08.2012Designation fee(s) paid 
06.08.2012Examination fee paid 
Examination procedure03.08.2012Amendment by applicant (claims and/or description)
06.08.2012Examination requested  [2012/47]
23.04.2014Application deemed to be withdrawn, date of legal effect  [2014/52]
03.06.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/52]
Fees paidRenewal fee
10.01.2013Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.01.201404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO9925828  (ZYMOGENETICS INC [US]) [X] 1-3,5-14 * the whole document * * sequences 1, 19 * * page 75, lines 18-23 * * page 75, lines 24-28 * * page 76, line 4 - page 77, line 3 * * page 83, lines 1-34 * [Y] 1-15;
 [XY]WO2009116861  (PODICEPS B V [NL], et al) [X] 9,11 * the whole document * * page 16, lines 1-5 * * sequences 1, 19 * [Y] 1-15;
 [Y]  - ZHU Y ET AL, "Cloning, expression, and initial characterization of a novel cytokine-like gene family", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, (20020801), vol. 80, no. 2, doi:10.1006/GENO.2002.6816, ISSN 0888-7543, pages 144 - 150, XP002269508 [Y] 1-15 * the whole document * * page 145; figure 2A * * page 146; table 1 *

DOI:   http://dx.doi.org/10.1006/geno.2002.6816
 [Y]  - SOUZA J J S ET AL, "Cytokine-like FAM3D gene is associated to diabetes mellitus in pancreatic adenocarcinoma", PANCREAS, RAVEN PRESS, NEW YORK, NY, US, (20061101), vol. 33, no. 4, ISSN 0885-3177, page 498, XP009172489 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1097/00006676-200611000-00208
International search[X]US6245550  (ABDEL-MEGUID SHERIN S [US], et al);
 [Y]US2007203225  (HAVEL PETER J [US], et al);
 [Y]US2006234913  (ARBIT EHUD [US], et al);
 [A]US2004137575  (CONKLIN DARRELL C [US], et al)
 [AP]  - WANG ET AL., "Cytokines in the Progression of Pancreatic Beta Cell Dysfunction.", INT J ENDOCRINOL, (20101114), vol. 2010, pages 1 - 10, XP009172487

DOI:   http://dx.doi.org/10.1155/2010/515136
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.